Houston is celebrating 50 years since the Apollo moon landing. Here are somethings you can expect to see in Houston during Space City Month. Photo via NASA.gov

Fifty years ago, NASA sent a crew of astronauts to the moon and back while a team controlled the mission from the Johnson Space Center in Houston.

In honor of this history-making experience, the Space City is playing host to Space City Month this July, and it's a time to recognize the science and sacrifice it took to put man on the moon, as well as look forward to the future of NASA and space exploration.

Restored Apollo 11 mission control center

Photo via NASA.gov

Ever wonder what it was like to be in the room where it happened — where Neil Armstrong radioed in to give his famous, "One small step for man, one giant leap for mankind" statement? Now you can.

Space Center Houston has restored the mission control center where dozens of professionals kept watch and records over the astronauts making their harrowing journey. The exhibit just opened, and visitors can sign up for free tickets.

The restoration has been years in the making. Retired mission control experts contributed to the exhibit and the efforts were even funded by a Kickstarter campaign that raised over $500,000.

Special NASA programming

The video and audio coverage were an incredible component for the Apollo missions to deliver to an earthly audience. Now, celebrating 50 years, NASA's bringing back the special programming.

From noon to 2 pm on July 19, the organization will broadcast live from NASA's newly-restored Apollo mission control room at Johnson Space Center in Houston, along with a couple other historic locations like the Kennedy Space Center in Florida, the Marshall Space Flight Center in Huntsville, Alabama, the Smithsonian National Air, and the Space Museum in Washington.

Watch the show on something that wasn't available in 1969: The internet. More specifically, find the stream on the NASA Live page.

InnovationMap interviews with space innovators

Tim Kopra

Tim Kopra spent over 244 days in space, and now he's using his tech background to invest in emerging energy companies. Courtesy of Tim Kopra

Much like we did for Pride Month, our Featured Innovator section — where we run weekly innovator interviews — will be taken over by a special series. Four different interviews with four different space innovators will be published on Wednesdays for the rest of the month.

Can't wait until Wednesday? Check out this interview we did with an astronaut turned venture capital investor, Tim Kopra. He spent a career total of 244 days in space before re-entering earth's orbit and civilian life. As different as his career is now compared to life in space, he actually sees a similarity.

"On face value, it may sound like an odd match, taking someone with a tech and operational background and putting them in venture, but quite frankly it feels very familiar to me because my career has really been focused on working on complex technology and operations with very small teams," Kopra tells InnovationMap in the article. "It's not just a theoretical understanding of the technology, but understanding how to use the technology and how it works."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.